Literature DB >> 23905133

Dilated cardiomyopathy: an anaesthetic challenge.

Haramritpal Kaur1, Ranjana Khetarpal, Shobha Aggarwal.   

Abstract

Idiopathic dilated cardiomyopathy is a primary myocardial disease of unknown etiology characterized by left ventricular or biventricular dilation and impaired contractility. Depending upon diagnostic criteria used, the reported annual incidence varies between 5 and 8 cases per 100,000 populations. Dilated cardiomyopathy is defined by presence of: a) fractional myocardial shortening less than 25% (>2SD) and/or ejection fraction less than 45% (>2SD) and b) Left Ventricular End Diastolic Diameter (LVEDD) greater than 117% excluding any known cause of myocardial disease. Such cases are always a challenge to the anesthesiologist as they are most commonly complicated by progressive cardiac failure. We report the anesthetic management of a patient with dilated cardiomyopathy undergoing surgery for carcinoma breast.

Entities:  

Keywords:  Anaesthetic management; Dilated cardiomyopathy; Idiopathic

Year:  2013        PMID: 23905133      PMCID: PMC3708228          DOI: 10.7860/JCDR/2013/5390.3069

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  8 in total

1.  Implanted cardiac pacemakers and defibrillators in anaesthetic practice.

Authors:  S Senthuran; W D Toff; A Vuylsteke; P M Solesbury; D K Menon
Journal:  Br J Anaesth       Date:  2002-05       Impact factor: 9.166

Review 2.  Anesthetic considerations in patients with cardiomyopathies --a review.

Authors:  Prashan H Thiagarajah; Somasundaram Thiagarajah; Elizabeth A M Frost
Journal:  Middle East J Anaesthesiol       Date:  2009-10

3.  [Preanesthetic evaluation of cardiovascular reserve in a patient with dilated cardiomyopathy].

Authors:  T Oda; S Otani; N Yoshimura
Journal:  Masui       Date:  1996-04

Review 4.  The dilated cardiomyopathies: clinical aspects.

Authors:  L W Stevenson; J K Perloff
Journal:  Cardiol Clin       Date:  1988-05       Impact factor: 2.213

5.  Hypomagnesemia in heart failure with ventricular arrhythmias. Beneficial effects of magnesium supplementation.

Authors:  L Ceremuzyński; J Gebalska; R Wolk; E Makowska
Journal:  J Intern Med       Date:  2000-01       Impact factor: 8.989

6.  Effectiveness of resynchronization therapy in patients with end-stage heart failure.

Authors:  Sander G Molhoek; Jeroen J Bax; Lieselot van Erven; Marianne Bootsma; Eric Boersma; Paul Steendijk; Ernst E van der Wall; Martin J Schalij
Journal:  Am J Cardiol       Date:  2002-08-15       Impact factor: 2.778

7.  Anaesthetic induction in a child with end-stage cardiomyopathy.

Authors:  W S Schechter; C Kim; M Martinez; B F Gleason; D P Lund; F A Burrows
Journal:  Can J Anaesth       Date:  1995-05       Impact factor: 5.063

8.  Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial.

Authors:  Rakesh Sharma; Darrel P Francis; Bertram Pitt; Philip A Poole-Wilson; Andrew J S Coats; Stefan D Anker
Journal:  Eur Heart J       Date:  2004-06       Impact factor: 29.983

  8 in total
  4 in total

1.  Anaesthetic management of a patient with dilated cardiomyopathy for fracture femur surgery-a case report.

Authors:  Koramutla Pradeep Kumar; Gudaru Jagadesh
Journal:  J Clin Diagn Res       Date:  2014-03-15

2.  Anaesthesia Application for Cardiac Denervation in a Patient with Long QT Syndrome and Cardiomyopathy.

Authors:  Ümit Karadeniz; Aslı Demir; Rabia Koçulu
Journal:  Turk J Anaesthesiol Reanim       Date:  2016-02-01

3.  Effects of stem cell therapy on dilated cardiomyopathy.

Authors:  Rong Jiao; Yuan Liu; Wen-Jian Yang; Xiao-Yan Zhu; Jin Li; Qi-Zhu Tang
Journal:  Saudi Med J       Date:  2014-12       Impact factor: 1.484

4.  Anesthetic management of hysterosalpingooophorectomy in a case with severe idiopathic dilated cardiomyopathy.

Authors:  Cengiz Kaya; Ersin Koksal; Yasemin Burcu Ustun; Yasemin Semizoglu; Nurullah Yilmaz
Journal:  Med Arch       Date:  2014
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.